M.D. Sass LLC’s Avantor AVTR Stock Holding History

M.D. Sass LLC’s Portfolio AVTR Stock Details AVTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,780,762	Closed	-$36.6M	–	33
2023 Q2	$36.6M	Buy	1,780,762 +535,766	+43%	+$10.8M	4.85%	8
2023 Q1	$26.3M	Buy	+1,244,996	New	+$28.4M	3.28%	13

Other funds holding AVTR

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

NMC

New Mountain Capital New York $139M AUM 26.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

M.D. Sass LLC's AVTR Position: Q3 2023 in Review

M.D. Sass LLC sold out of Avantor (AVTR) in Q3 2023, closing a stake of 1,780,762 shares — an estimated $36.6M sold.

M.D. Sass LLC first reported a position in AVTR in Q1 2023 and held it in 2 quarters. The position peaked at $36.6M in Q2 2023. 438 funds tracked by Wall St. Rank hold AVTR as of Q3 2023.

M.D. Sass LLC reported no remaining Avantor position as of Q3 2023 after selling out during the quarter.
M.D. Sass LLC sold 1,780,762 Avantor shares in Q3 2023, an estimated $36.6M.
M.D. Sass LLC first reported a position in Avantor in Q1 2023 and held it in 2 quarters.
M.D. Sass LLC's Avantor position peaked at $36.6M in Q2 2023.
438 funds tracked by Wall St. Rank held Avantor as of Q3 2023.

Based on M.D. Sass LLC's 13F filing for Q3 2023, filed 14 Nov 2023.